Literature DB >> 7294602

[Factorial structure of the Hamilton depression scale. I].

J D Guelfi, J F Dreyfus, S Ruschel, C Blanchard, P Pichot.   

Abstract

A development version (N I M H 67) of the Hamilton depression rating scale with 26 items was scored on 125 depressed inpatients recently hospitalized for a major non schizophrenic depressive illness. The data were obtained before any antidepressant treatment or after an adequate wash out period. A principal component factorial analysis with Varimax rotation was used. Computer simulations showed that only 2 factors were really outside the non significant range. A criterion is defined to allow the choice of an optimal saturation threshold for inclusion of an item in a factor. It assigns 25 of the 26 items of the scale to one of 2 independent factors: depression and anxiety-somatization.

Entities:  

Mesh:

Year:  1981        PMID: 7294602

Source DB:  PubMed          Journal:  Ann Med Psychol (Paris)        ISSN: 0003-4487            Impact factor:   0.380


  5 in total

1.  Resolving a disagreement in a clinical team: overcoming conflicting views about the role of family therapy in an outpatient treatment programme for anorexia nervosa.

Authors:  N Godart; F Perdereau; Z Rein; F Curt; I Kaganski; R Lucet; M Corcos; J Fermanian; M Flament; P Jeammet
Journal:  Eat Weight Disord       Date:  2006-12       Impact factor: 4.652

2.  Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating Scale.

Authors:  C Goldberger; J D Guelfi; D V Sheehan
Journal:  Psychopharmacol Bull       Date:  2011-09-15

3.  Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression.

Authors:  Raphaelle Richieri; Laurent Boyer; Jean Farisse; Cecile Colavolpe; Olivier Mundler; Christophe Lancon; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-07       Impact factor: 9.236

4.  A double-blind controlled clinical trial comparing fluvoxamine with imipramine.

Authors:  J D Guelfi; J F Dreyfus; P Pichot
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

Authors:  Daniela Silva Moura; Serge Sultan; Sophie Georgin-Lavialle; Nathalie Pillet; François Montestruc; Paul Gineste; Stéphane Barete; Gandhi Damaj; Alain Moussy; Olivier Lortholary; Olivier Hermine
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.